6/17/25 16:11  | 6/13/25  | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | CFO | S.dm | -33 | 2.72 | 0 | -12 | -5 | 226 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/17/25 16:11  | 6/13/25  | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | CFO | M.d | 0 | 0.00 | 0 | 38 | 20 | 226 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/20/25 16:33  | 3/18/25  | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | CFO | S | -5 | 0.5990 | 0 | -9 | -4 | 201 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/22/24 17:59  | 8/20/24  | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | CFO | M.d | 0 | 0.00 | 0 | 7 | 7 | 108 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/22/24 17:59  | 8/20/24  | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | CFO | S.d | -2 | 1.23 | 0 | -2 | -2 | 108 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/21/24 16:38  | 3/19/24  | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | SVP,Fina | S | -6 | 2.09 | 0 | -3 | -3 | 86 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/22/23 16:10  | 12/20/23  | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | SVP,Fina | S | -3 | 1.38 | 0 | -2 | -4 | 49 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/19/23 19:58  | 12/17/23  | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | SVP,Fina | M.d | 0 | 0.00 | 0 | 7 | 16 | 51 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/20/23 18:43  | 3/16/23  | CTMX | Cytomx Therapeutics, Inc. |  | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | SVP,Fina | S | -1 | 1.98 | 0 | -1 | -1 | 38 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |